(2023). Real-world evidence from the first online healthcare analytics platform-Livingstone. Validation of its descriptive epidemiology module. Plos Digit Health, 2, e0000310. http://doi.org/10.1371/journal.pdig.0000310.
(2012). Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugs. Diabetes Obes Metab. http://doi.org/10.1111/j.1463-1326.2011.01552.x.
(2012). What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes. J Clin Endocrinol Metab. http://doi.org/10.1210/jc.2012-3034.
(2012). Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study. J Clin Endocrinol Metab. http://doi.org/10.1210/jc.2012-1690.
(2013). The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010). Child Adolesc Psychiatry Ment Health. http://doi.org/10.1186/1753-2000-7-34.
(2013). Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study. BMJ Open. http://doi.org/10.1136/bmjopen-2013-004025.
(2013). The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010. Diabetes Obes Metab. http://doi.org/10.1111/dom.12123.
(2013). Omega-3 Fatty acids and mortality outcome in patients with and without type 2 diabetes after myocardial infarction: a retrospective, matched-cohort study. Clin Ther. http://doi.org/10.1016/j.clinthera.2012.11.008.
(2014). External validation of the UKPDS risk engine in incident type 2 diabetes: a need for new type 2 diabetes-specific risk equations. Diabetes Care. http://doi.org/10.2337/dc13-1159.
(2014). How many people inject insulin? UK estimates from 1991 to 2010. Diabetes Obes Metab. http://doi.org/10.1111/dom.12260.